These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 14660730)

  • 1. Lipiodol solution of 188Re-HDD as a new therapeutic agent for transhepatic arterial embolization in liver cancer: preclinical study in a rabbit liver cancer model.
    Paeng JC; Jeong JM; Yoon CJ; Lee YS; Suh YG; Chung JW; Park JH; Chung JK; Son M; Lee MC
    J Nucl Med; 2003 Dec; 44(12):2033-8. PubMed ID: 14660730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 188Re-HDD/lipiodol therapy for hepatocellular carcinoma: a phase I clinical trial.
    Lambert B; Bacher K; Defreyne L; Gemmel F; Van Vlierberghe H; Jeong JM; Dierckx RA; Van de Wiele C; Thierens H; De Vos F
    J Nucl Med; 2005 Jan; 46(1):60-6. PubMed ID: 15632035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biologic dosimetry of 188Re-HDD/lipiodol versus 131I-lipiodol therapy in patients with hepatocellular carcinoma.
    De Ruyck K; Lambert B; Bacher K; Gemmel F; De Vos F; Vral A; de Ridder L; Dierckx RA; Thierens H
    J Nucl Med; 2004 Apr; 45(4):612-8. PubMed ID: 15073257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of acetylated HDD kit for preparation of 188Re-HDD/lipiodol.
    Lee YS; Jeong JM; Kim YJ; Chang YS; Lee HJ; Son M; Lee JW; Yoon HS; Kang WJ; Lee DS; Chung JK; Lee MC; Suh YG
    Appl Radiat Isot; 2007 Jan; 65(1):64-9. PubMed ID: 17010628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and biodistribution of rhenium-188 ECD/Lipiodol in rats following hepatic arterial injection.
    Luo TY; Hsieh BT; Wang SJ; Lin WY; Lee TW; Shen LH; Su MJ
    Nucl Med Biol; 2004 Jul; 31(5):671-7. PubMed ID: 15219287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 188Re-HDD/lipiodol for treatment of hepatocellular carcinoma: a feasibility study in patients with advanced cirrhosis.
    Lambert B; Bacher K; De Keukeleire K; Smeets P; Colle I; Jeong JM; Thierens H; Troisi R; De Vos F; Van de Wiele C
    J Nucl Med; 2005 Aug; 46(8):1326-32. PubMed ID: 16085590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (188)Re-HDD/lipiodol therapy for hepatocellular carcinoma: an activity escalation study.
    Lambert B; Bacher K; Defreyne L; Van Vlierberghe H; Jeong JM; Wang RF; van Meerbeeck J; Smeets P; Troisi R; Thierens H; De Vos F; Van de Wiele C
    Eur J Nucl Med Mol Imaging; 2006 Mar; 33(3):344-52. PubMed ID: 16333675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcatheter arterial embolization with 188Rhenium-HDD-labeled iodized oil in rabbit VX2 liver tumor.
    Yoon CJ; Chung JW; Park JH; Kim YI; Lee KH; Jeong JM; Paeng JC
    J Vasc Interv Radiol; 2004 Oct; 15(10):1121-8. PubMed ID: 15466799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of the Oak Ridge National Laboratory tungsten-188/rhenium-188 generator for preparation of the rhenium-188 HDD/lipiodol complex for trans-arterial liver cancer therapy.
    Jeong JM; Knapp FF
    Semin Nucl Med; 2008 Mar; 38(2):S19-29. PubMed ID: 18243839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 188 Re-labelled long chain alkyl diaminedithiol for therapy of liver cancer.
    Lee YS; Jeong JM; Kim YJ; Chung JW; Park JH; Suh YG; Lee DS; Chung JK; Lee MC
    Nucl Med Commun; 2002 Mar; 23(3):237-42. PubMed ID: 11891481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipiodol solution of a lipophilic agent, (188)Re-TDD, for the treatment of liver cancer.
    Jeong JM; Kim YJ; Lee YS; Ko JI; Son M; Lee DS; Chung JK; Park JH; Lee MC
    Nucl Med Biol; 2001 Feb; 28(2):197-204. PubMed ID: 11295430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inoperable hepatocellular carcinoma: transarterial 188Re HDD-labeled iodized oil for treatment--prospective multicenter clinical trial.
    Kumar A; Srivastava DN; Chau TT; Long HD; Bal C; Chandra P; Chien le T; Hoa NV; Thulkar S; Sharma S; Tam le H; Xuan TQ; Canh NX; Pant GS; Bandopadhyaya GP
    Radiology; 2007 May; 243(2):509-19. PubMed ID: 17456873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of 4-hexadecyl-4,7-diaza-1,10-decanedithiol (HDD) kit for the preparation of the liver cancer therapeutic agent Re-188-HDD/lipiodol.
    Banka VK; Moon SH; Jeong JM; Seelam SR; Lee YS; Kim YJ; Lee DS; Chung JK
    Nucl Med Biol; 2015 Mar; 42(3):317-22. PubMed ID: 25537725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A report on the implementation aspects of the International Atomic Energy Agency's first doctoral coordinated research project, "Management of liver cancer using radionuclide methods with special emphasis on trans-arterial radio-conjugate therapy and internal dosimetry".
    Padhy AK; Dondi M
    Semin Nucl Med; 2008 Mar; 38(2):S5-12. PubMed ID: 18243843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary results of transarterial rhenium-188 HDD lipiodol in the treatment of inoperable primary hepatocellular carcinoma.
    Sundram F; Chau TC; Onkhuudai P; Bernal P; Padhy AK
    Eur J Nucl Med Mol Imaging; 2004 Feb; 31(2):250-7. PubMed ID: 15129708
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of MT1-MMP and its significance in rabbit VX2 tumor tissues after transarterial embolization with hydroxyapatite nanoparticles].
    Xu T; Chen XP; Guo YX; Li D; Lu L; Huan GZ; Zhang WG
    Zhonghua Wai Ke Za Zhi; 2008 Apr; 46(8):606-9. PubMed ID: 18844058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heated lipiodol as an embolization agent for transhepatic arterial embolization in VX2 rabbit liver cancer model.
    Cao W; Wan Y; Liang ZH; Duan YY; Liu X; Wang ZM; Liu YY; Zhu J; Liu XT; Zhang HX
    Eur J Radiol; 2010 Feb; 73(2):412-9. PubMed ID: 19091502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of transarterial embolization with arsenic trioxide oil emulsion in a rabbit VX2 liver tumor model.
    Kim HJ; Shin JH; Kim TH; Kim EY; Park YS; Park CS; Song HY
    J Vasc Interv Radiol; 2009 Oct; 20(10):1365-70. PubMed ID: 19713126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advantage of 188Re-radiopharmaceuticals in hepatocellular cancer and liver metastases.
    Liepe K; Kotzerke J; Lambert B
    J Nucl Med; 2005 Aug; 46(8):1407-8; author reply 1407-8. PubMed ID: 16085601
    [No Abstract]   [Full Text] [Related]  

  • 20. Thyroid uptake and radiation dose after (131)I-lipiodol treatment: is thyroid blocking by potassium iodide necessary?
    Bacher K; Brans B; Monsieurs M; De Winter F; Dierckx RA; Thierens H
    Eur J Nucl Med Mol Imaging; 2002 Oct; 29(10):1311-6. PubMed ID: 12271412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.